Major cancer study tests best ways to protect patients from dangerous infections after chemo

This study looked at different ways to prevent and manage neutropenia, a dangerous drop in white blood cells that leaves cancer patients vulnerable to serious infections after chemotherapy. Researchers followed 3,000 patients with various cancers to see which treatment approaches worked best at preventing infections and severe neutropenia, while also checking safety and how treatments affected patients' quality of life. The goal was to gather real-world evidence to help doctors choose the best protective strategies for their patients.